Early Diagnosis of Alzheimer's Disease - Benefits, Challenges and Recent DevelopmentsGlobalDataMarch 31, 2011 5 Pages - SKU: GBDT6428001 |
|
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
5/1/2013 | published by: BCC Research
This report provides:
An overview of the global market for Alzheimer's disease therapeutic and diagnostic technologies
Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth
|
read more...
|
$5,450.00
|
|
Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer’s Disease
5/14/2013 | published by: GBI Research
Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer’s Disease Summary GBI Research’s report “Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI)
|
read more...
|
$3,500.00
|
|
Alzheimer Disease Treatment Drugs Markets in China
4/15/2013 | published by: Asia Market Information & Development Company
Alzheimer Disease Treatment Drugs Markets in China China's demand for alzheimer disease treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will
|
read more...
|
$2,000.00
|
|
Alzheimer's Disease – Pipeline Review, H1 2013
2/28/2013 | published by: Global Markets Direct
Alzheimer's Disease – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Alzheimer's Disease - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Alzheimer's Disease,
|
read more...
|
$2,500.00
|
|
Dementia Associated With Alzheimer's Disease – Pipeline Review, H1 2013
3/28/2013 | published by: Global Markets Direct
Dementia Associated With Alzheimer's Disease – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on
|
read more...
|
$2,000.00
|
|
Vaccines 2012-16 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments
9/19/2012 | published by: Kalorama Information
This report examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging
|
read more...
|
$1,500.00
|
|
What's Next In Vaccines (Malaria, Diabetes, Alzheimer's, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)
6/5/2012 | published by: Kalorama Information
Vaccines are one of the most dynamic parts of the pharmaceutical business today but future growth will depend on a considerable amount of potential vaccines in the pipeline.This Kalorama Information report What's Next in Vaccines? examines and
|
read more...
|
$3,995.00
|
|
Kalorama Vaccine Market Research Report Bundle (Vaccines 2012, What's Next in Vaccines, Vaccine Production Markets)
10/18/2012 | published by: Kalorama Information
Vaccines are an important part of the business model of top pharmaceutical companies. The success of several recent vaccine product introductions has been of great interest to pharma R&D efforts. The high growth
|
read more...
|
$3,995.00
|
|
EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2022
2/15/2013 | published by: GlobalData
EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2022 Summary Alzheimer’s disease is the most common cause of dementia in people age 60 years and older and accounts for approximately 75% of the total dementia cases worldwide
|
read more...
|
$3,995.00
|
|
Research Report on China’s Anti-Alzheimer’s Disease (AD) Drug Market, 2013-2017
1/28/2013 | published by: China Research and Intelligence Co., Ltd.
By the end of 2011, people aged 60 and above reached 185 million in China, accounting for 13.7% of the population, with an increase of 0.47 percentage point compared with that at the end of
|
read more...
|
$2,800.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Alzheimer's Disease Reports
- Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer’s Disease
- Alzheimer Disease Treatment Drugs Markets in China
- Dementia Associated With Alzheimer's Disease – Pipeline Review, H1 2013
- Alzheimer's Disease – Pipeline Review, H1 2013
- EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2022